Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Esculin sodium is the sodium salt form of esculin (also known as æsculin or esculin), a coumarin glucoside naturally occurring in horse chestnut (Aesculus hippocastanum), California buckeye (Aesculus californica), and other plants[1][5]. It is primarily used in microbiology laboratories as a diagnostic agent to identify bacterial species such as Enterococci and Listeria; all strains of Group D Streptococci hydrolyze aesculin in bile-containing media[8][5]. In medicine and research settings (mainly outside the US/EU regulatory framework), it has been used for its vasoprotective properties—improving capillary permeability and fragility by inhibiting catabolic enzymes like hyaluronidase and collagenase. Esculin also exhibits antioxidant activity that may contribute to anti-inflammatory effects[2][3][6]. The compound is rarely absorbed systemically when applied topically but can be absorbed if administered with other ingredients rectally or on open wounds[3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on esculin sodium.